Pacific Biosciences of California Inc

PACB

$5.46

-82.6% last 12 months

Cathie Wood Holding value: $149 Million Ken Griffin Holding value: $12.3 Million Jim Simons Holding value: $4.74 Million Ken Fisher Holding value: $300 Thousand Steven Cohen Holding value: $0 Jeremy Grantham Holding value: $0 Joel Greenblatt Holding value: $0 Mario Gabelli Holding value: $0 George Soros Holding value: $0 Prem Watsa Holding value: $0

Market Cap

$1.23 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$3.85 - $36.36

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

-6.99x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $1.23 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $1.16 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. -82.6%
52-Week High Highest share price in the last 52 weeks. $36.36
52-Week Low Lowest share price in the last 52 weeks. $3.85
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 2.5
Outstanding Shares The number of shares the company has issued and are held by stockholders. 224 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 7.11 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. -6.99
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 102.95
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. -$0.83
Price to Sales Ratio Market cap divided by the revenue in the most recent year. Infinity
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 1.82
Enterprise Value to Revenue Enterprise value divided by revenue 8.6
Enterprise Value to EBIT Enterprise Value divided by EBIT -5.19
Total Debt to Enterprise Value Total debt divided by enterprise value 0.77
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 1.22

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $135 Million
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $60.5 Million
EBIT Earnings before tax and interest payments. -$223 Million
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. -$175 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -130.14%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -6.8%
Return on Equity Equity divided by market cap. -23.86%
Return on Assets Indicates a company's profitability in relation to its total assets. -9.05%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -11.89%

Insider trades

No purchases

110,792.0 shares sold (2 transactions)

No purchases

No sells

No purchases

67,664.0 shares sold (5 transactions)

No purchases

3,573.0 shares sold (1 transactions)

Q3 2021 Q4 2021 Q1 2022 Q2 2022

Similar stocks

Illumina Inc
Illumina Inc
Nanostring Technologies Inc
Nanostring Technologies Inc
General Electric Co.
General Electric Co.
Luminex Corp
Luminex Corp
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Fluidigm Corp
Fluidigm Corp
Perkinelmer, Inc.
Perkinelmer, Inc.

News

We Just Learned Something New! After Pacific Biosciences of California Inc. (NASDAQ: PACB)’s 27.57% Gain This Week

We Just Learned Something New! After Pacific Biosciences of California Inc. (NASDAQ: PACB)’s 27.57% Gain This Week

During the last session, Pacific Biosciences of California Inc. (NASDAQ:PACB)’s traded shares were 6.55 million, with the beta value of the company hitting 1...

Marketing Sentinel Marketing Sentinel, about 20 hours ago
Pacific Biosciences of California Inc.: Why Investors Shouldn’t Get Rid Of PACB Stock In 2022

Pacific Biosciences of California Inc.: Why Investors Shouldn’t Get Rid Of PACB Stock In 2022

In today’s recent session, 1.27 million shares of the Pacific Biosciences of California Inc. (NASDAQ:PACB) have been traded, and its beta is 1.55. Most recen...

Marketing Sentinel Marketing Sentinel, 4 days ago
This Week’s -9.13% Loss In Pacific Biosciences of California Inc. (NASDAQ: PACB) Taught Us Something New

This Week’s -9.13% Loss In Pacific Biosciences of California Inc. (NASDAQ: PACB) Taught Us Something New

Pacific Biosciences of California Inc. (NASDAQ:PACB)’s traded shares stood at 7.86 million during the last session, with the company’s beta value hitting 1.4...

Marketing Sentinel Marketing Sentinel, 9 days ago
Where Do Analysts Think The Pacific Biosciences of California Inc. (NASDAQ: PACB) Is Going

Where Do Analysts Think The Pacific Biosciences of California Inc. (NASDAQ: PACB) Is Going

Pacific Biosciences of California Inc. (NASDAQ:PACB) price is hovering higher on Wednesday, June 15, jumping 5.00% above its previous close. >> 5 Best Growth...

Stocks Register Stocks Register, 10 days ago
Never miss a trade
To improve your user experience we use cookies.